SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-24-039242
Filing Date
2024-03-27
Accepted
2024-03-27 06:07:55
Documents
10
Period of Report
2024-03-27

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm249892d1_6k.htm 6-K 14811
2 EXHIBIT 99.1 tm249892d1_ex99-1.htm EX-99.1 7530
3 EXHIBIT 99.2 tm249892d1_ex99-2.htm EX-99.2 15441
4 EXHIBIT 99.3 tm249892d1_ex99-3.htm EX-99.3 20025
5 EXHIBIT 99.4 tm249892d1_ex99-4.htm EX-99.4 48368
6 EXHIBIT 99.5 tm249892d1_ex99-5.htm EX-99.5 27923
7 GRAPHIC tm249892d1_ex99-2img001.jpg GRAPHIC 3464
8 GRAPHIC tm249892d1_ex99-3img001.jpg GRAPHIC 2975
9 GRAPHIC tm249892d1_ex99-4img001.jpg GRAPHIC 8590
10 GRAPHIC tm249892d1_ex99-5img001.jpg GRAPHIC 13039
  Complete submission text file 0001104659-24-039242.txt   174626
Mailing Address INDUSTRIEPARK ZWIJNAARDE 7 BUILDING C B-9052 ZWIJNAARDE C9 B-9052
Business Address INDUSTRIEPARK ZWIJNAARDE 7 BUILDING C B-9052 ZWIJNAARDE C9 B-9052 32 (9) 310 34 00
ARGENX SE (Filer) CIK: 0001697862 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38097 | Film No.: 24785658
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)